BERKELEY HEIGHTS, N.J., March 8, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”) today announced that the Company will present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference being held at The Ritz Carlton in Laguna Niguel, California. Spiro Rombotis, President and Chief Executive Officer, will provide an overview of the Company and its progress in key programs on Monday, March 15, 2010 at 2:00 p.m. Pacific.
